Home - Medical Policies - Alabama
Policies & Guidelines
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing Management
- Hemophilia Drug Management
- Medical Policies
- PET, MRI, MRA, CT, CTA/CCTA
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Radiation Therapy Management (RTM)
- Self-Administered Drug Policies
- Transgender Services
Genetic Testing Management Policies
Effective March 1, 2020, Blue Cross and Blue Shield of Alabama partners with AIM Specialty Health®, an independent company, to administer genetic testing solutions for our customers.
For more information about the Genetic Testing program, click here.
Node: bclrgrpappp1002.corp.bcbsal.org:8080